Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia B, Congenital”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03596814
What this trial is testing

MOTHIF II : THERAPEUTIC MANAGEMENT AND USE OF CLOTTING FACTORS IN HEMOPHILIA A & B IN FRANCE II

Who this might be right for
Hemophilia
Nantes University Hospital 2,072
Not applicableNot Yet RecruitingNCT07719647
What this trial is testing

Ultrasound Assessment of Joint Health in Patients With Mild Hemophilia (Factor Levels 5-40%)

Who this might be right for
Mild Hemophilia
Assistance Publique - Hôpitaux de Paris 150
Early research (Phase 1)Looking for participantsNCT06349473
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

Who this might be right for
Healthy ParticipantsHemophilia AHemophilia B+1 more
Equilibra Bioscience LLC 31
Testing effectiveness (Phase 2)Study completedNCT03091751
What this trial is testing

Efficacy and Safety of AlphaNine Versus BeneFIX in Patients With Severe Hereditary Haemophilia B

Who this might be right for
Hemophilia B
Grifols Biologicals, LLC 13
Not applicableEnded earlyNCT03248141
What this trial is testing

Understanding Hemophilia A and B Drug Dosage Administration Patterns

Who this might be right for
Hemophilia AHemophilia B
Pfizer 11
Early research (Phase 1)Study completedNCT02919800
What this trial is testing

A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male

Who this might be right for
Hemophilia A or B With Inhibitors
OPKO Health, Inc. 32
Not applicableStudy completedNCT03741881
What this trial is testing

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

Who this might be right for
Haemophilia AHaemophilia A With InhibitorsHaemophilia B+1 more
Novo Nordisk A/S 231
Early research (Phase 1)Study completedNCT01708564
What this trial is testing

A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B

Who this might be right for
Hemophilia
rEVO Biologics 15
Large-scale testing (Phase 3)Study completedNCT06399289
What this trial is testing

Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy

Who this might be right for
Hemophilia B
CSL Behring 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT01687608
What this trial is testing

Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B

Who this might be right for
Hemophilia B
Baxalta now part of Shire 30
Large-scale testing (Phase 3)WithdrawnNCT06297486
What this trial is testing

Study of a Gene Therapy Treatment for Hemophilia A

Who this might be right for
Hemophilia A
Spark Therapeutics, Inc.
Early research (Phase 1)Study completedNCT01228669
What this trial is testing

Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B+1 more
Novo Nordisk A/S 52
Large-scale testing (Phase 3)Study completedNCT02250573
What this trial is testing

An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Surgery

Who this might be right for
Haemophilia B
Bio Products Laboratory
Early research (Phase 1)UnknownNCT02888223
What this trial is testing

Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A

Who this might be right for
Hemophilia A
Sinocelltech Ltd. 16
Large-scale testing (Phase 3)UnknownNCT05487976
What this trial is testing

Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor

Who this might be right for
Hemophilia AHemophilia B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 50
Large-scale testing (Phase 3)Study completedNCT02740335
What this trial is testing

Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.

Who this might be right for
Significant Bleeding Risk
Octapharma 208
Testing effectiveness (Phase 2)Ended earlyNCT04434001
What this trial is testing

ZEPLAST- PED: ZEro_PLASma Trial in Small Infants Undergoing Cardiac Surgery

Who this might be right for
BleedingCardiac DefectSurgery--Complications+4 more
IRCCS Policlinico S. Donato 40
Testing effectiveness (Phase 2)UnknownNCT05441553
What this trial is testing

Evaluate the Safety and Efficacy of VGB-R04 in Adult Hemophilia B Patients

Who this might be right for
Hemophilia B
Shanghai Vitalgen BioPharma Co., Ltd. 26
Early research (Phase 1)Study completedNCT01561924
What this trial is testing

Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 17
Large-scale testing (Phase 3)Study completedNCT00243659
What this trial is testing

Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer 30
Next Page